1. Home
  2. |Insights
  3. |Mere Demonstration At A Trade Show Does Not Constitute Infringing Use

Mere Demonstration At A Trade Show Does Not Constitute Infringing Use

Client Alert | 1 min read | 09.11.08

For purposes of establishing personal jurisdiction, mere demonstration of an allegedly infringing device at a trade show does not constitute "use" under the patent laws, a Federal Circuit panel concludes in Medical Solutions, Inc. v. C Change Surgical LLC (No. 2007-1163; September 9, 2008).

Defendant C Change Surgical LLC demonstrated an allegedly infringing medical device at a 5-day trade show in the District of Columbia. Other than conducting the demonstration, C Change Surgical had no contacts with the District of Columbia and did no business there. To obtain personal jurisdiction under DC's long-arm statute, plaintiff Medical Solutions, Inc. attempted to show that C Change's demonstrations at the trade show constituted a "use" under 35 U.S.C. § 271(a). But the evidence failed to reveal that the allegedly infringing device practiced all of the elements of any claim.

Thus, because the allegedly infringing device was not "put into action or service" sufficient to constitute "use" under the patent laws, there was no basis to invoke the District of Columbia's long-arm statute, and therefore the Federal Circuit affirmed the trial court's dismissal for lack of personal jurisdiction.

Contacts

Insights

Client Alert | 5 min read | 08.21.26

FTC Proposes Enforcement Policy Statement on Personalized Pricing: What Businesses Need to Know

On August 19, 2026, the Federal Trade Commission (FTC) announced a proposed Enforcement Policy Statement on personalized pricing — the practice of companies using consumers’ personal data to set individualized prices, discounts, coupons, or other incentives. The proposed statement, which is open for public comment for 30 days following publication in the Federal Register, marks a major step up in the FTC’s focus on data-driven pricing strategies and puts businesses across industries on notice that undisclosed or inadequately disclosed personalized pricing will not be tolerated. Importantly, while the proposed statement is not a binding legal requirement and does not create new legal obligations, it serves as an enforcement warning that the FTC is prepared to use its existing enforcement authority under Section 5 of the FTC Act (Section 5) and is also a potential harbinger of rulemaking. Businesses that engage in — or are considering — personalized pricing should carefully assess their disclosure practices and data collection procedures against the standards articulated in this statement....